|
| General Information | |||
|---|---|---|---|
| Term | hyperalphalipoproteinemia 1 | ID (Ontology) | DOID:0111369 (Human Disease) |
| Definition | A cholesterol-ester transfer protein deficiency characterized by elevated levels of alpha-lipoprotein in the blood that has_material_basis_in heterozygous mutation in the CETP gene on chromosome 16q13. | ||
| Also Known As | "HALP1" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
No relevant statements available
|
|||
|
||||||
autosomal genetic disease |__autosomal dominant disease_____________________ lipid metabolism disorder | |__cholesterol-ester transfer protein deficiency__| hyperalphalipoproteinemia 1 |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a |
autosomal dominant disease cholesterol-ester transfer protein deficiency |
||
| Part of | |||
|
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
|
External Crossreferences & Linkouts
|
|||
|
MESH:C564591 MIM:143470 NCI:C128806 SNOMEDCT_US_2023_03_01:238080004 UMLS_CUI:C0342883 |
|||